id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-032608-zw540s64	Elsayed, Hany Hasan	Dexamethasone for treatment of severe COVID-19, a surprise?	2020-09-24		.txt	text/plain	959	53	48	In fact, the Surviving Sepsis Campaign panel recently recommended that "mechanically ventilated patients with COVID-19 related ARDS should be managed similarly to other patients with acute respiratory failure in the ICU" [3] . In fact, Villar and his colleagues have published the largest meta-analysis of using dexamethasone treatment for the acute respiratory distress syndrome few months back and this has shown a mortality benefit [6] . In fact, 1772 patients with severe COVID-19 ARDS requiring mechanical ventilation in the RECOVERY trial did not receive steroids. I believe that most intensivists around the world were using dexamethasone for their patients with severe COVID-19 developing ARDS before the RECOVERY trial results were released based on the evidence they had on how to manage this unique entity from a variety of causes. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial	./cache/cord-032608-zw540s64.txt	./txt/cord-032608-zw540s64.txt